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Abstract
Rationale Dependence on drugs and alcohol is associated
with impaired impulse control, but deficits are rarely com-
pared across individuals dependent on different substances
using several measures within a single study.
Objectives We investigated impulsivity in abstinent
substance-dependent individuals (AbD) using three comple-
mentary techniques: self-report, neuropsychological and neu-
roimaging.We hypothesised that AbDs would show increased
impulsivity across modalities, and that this would depend on
length of abstinence.
Methods Data were collected from the ICCAM study: 57 con-
trol and 86 AbDs, comprising a group with a history of de-
pendence on alcohol only (n=27) and a group with history of
dependence on multiple substances (Bpolydrug^, n=59). All
participants completed self-report measures of impulsivity:
Barratt Impulsiveness Scale, UPPS Impulsive Behaviour
Scale, Behaviour Inhibition/Activation System and
Obsessive-Compulsive Inventory. They also performed three
behavioural tasks: Stop Signal, Intra-Extra Dimensional Set-
Shift and Kirby Delay Discounting; and completed a Go/
NoGo task during fMRI.
Results AbDs scored significantly higher than controls on self-
report measures, but alcohol and polydrug dependent groups
did not differ significantly from each other. Polydrug partici-
pants had significantly higher discounting scores than both con-
trols and alcohol participants. There were no group differences
on the other behavioural measures or on the fMRI measure.
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Conclusions The results suggest that the current set of self-
report measures of impulsivity is more sensitive in abstinent
individuals than the behavioural or fMRI measures of neuro-
nal activity. This highlights the importance of developing be-
havioural measures to assess different, more relevant, aspects
of impulsivity alongside corresponding cognitive challenges
for fMRI.
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Introduction
Impulsivity is action without forethought, involves premature
responding, poor response inhibition and low tolerance for
delay (Evenden 1999). It is frequently associated with sub-
stance dependence (Dalley et al. 2011; de Wit 2009; Perry
and Carroll 2008; Verdejo-García et al. 2008) and higher im-
pulsivity is related to polydrug use (McCown 1988; Semple
et al. 2005). Although humans use many different substances
legally and illegally, heroin, cocaine and alcohol are rated as
the most harmful in the UK (Nutt et al. 2010); these were the
focus of the present study.
When investigating the link with substance dependence,
impulsivity has been measured in many ways, using either
self-report questionnaires or behavioural measures (Verdejo-
García et al. 2008). However, self-report and behavioural
measures are rarely correlated (Bari and Robbins 2013;
Broos et al. 2012), as each measure looks at distinct attributes,
often conceptualised in very different ways. Self-report mea-
sures, such as the widely used Barratt Impulsiveness Scale
(BIS-11; Patton et al. 1995), are assumed to be relatively sta-
ble trait constructs, whilst behavioural measures are depen-
dent on specific strategies that may differ between individuals
and testing sessions (Bari and Robbins 2013). Whilst
self-report measures may be more ecologically valid,
they are reliant on individual insight and are susceptible to
bias (Verdejo-García et al. 2008).
Two commonly used cognitive paradigms are the Go/
NoGo Task (GNG), which measures the ability to inhibit a
response before it is initiated, and the Stop Signal Task
(SST), which measures inhibition of a response after it is ini-
tiated. Both tasks have revealed decreased inhibitory control
in cocaine dependence (Ersche et al. 2011; Fernández-Serrano
et al. 2012; Kaufman et al. 2003) and alcohol dependence
(Sjoerds et al. 2014). A recent meta-analysis of these tasks
(Smith et al. 2014) found decreased inhibitory control in alco-
hol and cocaine dependence, but not in opioid dependence.
However, there were very few studies using the GNG task in
opioid users and none using the SST. One study since has used
the SST in opioid dependence, finding increased impulsivity
(Liao et al. 2014).
Studies of the neural substrates of impulsivity emphasise
the importance of top-down control of subcortical structures,
such as the nucleus accumbens (ventral striatum) by frontal
brain regions particularly the orbitofrontal cortex (OFC), an-
terior cingulate cortex (ACC) and dorsolateral prefrontal cor-
tex (DLPFC; Aron et al. 2003; Hester and Garavan 2004;
Kaufman et al. 2003). The inferior frontal gyrus (IFG),
especially right sided, ACC and DLPFC are frequently
implicated in SST and GNG tasks (Chambers et al.
2009; Garavan et al. 2006; Simmonds et al. 2008).
Reduced activations associated with poorer inhibitory
control in stimulant users have been observed in the
ACC and pre-supplementary motor area (preSMA;
Kaufman et al. 2003; Hester and Garavan 2004; Li
et al. 2008), as well as the right superior frontal gyrus
(Hester and Garavan 2004) and right insula (Kaufman
et al. 2003). Reduced prefrontal activation associated
with decreased inhibitory control has also been observed
in alcohol dependent individuals (Li et al. 2009), whilst
neuroimaging studies comparing opioid dependent individ-
uals to controls have found performance impairments accom-
panied by reduced prefrontal, insula and limbic system re-
sponses (Forman et al. 2004; Fu et al. 2008).
Recent investigations of impulsivity pay particular at-
tention to the multifaceted nature of the construct and
suggest that different forms of impulsivity are influential
at different stages of dependence. For example, impul-
sive choice (measured using delay discounting and Iowa
Gambling Task measures) predicts relapse, whilst impul-
sive action (measured using SST) does not differentiate
abstinent and relapsed participants (Stevens et al. 2015).
High impulsive choice is associated with continued drug
use and poor maintenance of abstinence (Passetti et al.
2008; MacKillop and Kahler 2009; Washio et al. 2011;
Stevens et al. 2013; Stevens et al. 2014), whilst impul-
sive action is thought to be related to initial sensitivity
(Diergaarde et al. 2008; Broos et al. 2012). Stevens
et al. (2015) also suggest that behavioural measures are
more useful than trait measures for detecting relapse risk,
and imply that the different types of measures may be more
useful at the different stages of addiction.
A key question is the extent to which impulsivity
varies with abstinence. There is evidence for recovery
of executive functioning during abstinence (Sullivan
et al. 2000; Schulte et al. 2014; Stavro et al. 2013;
Fernández-Serrano et al. 2011), as well as more specific evi-
dence for normalisation of behavioural inhibitory control
(Hopwood et al. 2011; Morie et al. 2014; Bell et al. 2014).
However, findings are not consistent, with other studies
reporting that behavioural impulsivity is still elevated in ab-
stinent alcohol dependent participants with mean length of
abstinence of six months (Naim-Feil et al. 2014). It has been
suggested that abstinence exceeding 12 months may be
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critical in terms of recovery, as 65–75 % of AbDs relapse
within 12 months of treatment discharge (Sinha 2011). Poor
treatment retention and early relapse are associated with
higher impulsivity in dependence (Moeller et al. 2001;
Patkar et al. 2004; Evren et al. 2012) suggesting that
impulsivity mechanisms may be a determinant of
sustained abstinence, such that impulsivity measures
may be different in those who are able to maintain
abstinence longer. There is therefore a need for studies
that systematically examine variability in impulsivity as-
sociated with varying length of abstinence (extending
beyond 12 months).
The evidence for impulsivity in substance dependence
is not consistent, especially when we consider the dif-
ferent types of substance dependence (for a review, see
Smith et al. 2014). However, there has been little re-
search comparing groups with different dependencies
within a single study and the majority of papers have
fewer than 30 participants per group (Smith et al. 2014),
only providing sufficient power to detect moderate ef-
fect sizes in questionnaire and behavioural measures.
Therefore, the aim of the present study was to investi-
gate impulsivity measures across different modalities:
self-report, behavioural and neuroimaging, in a large
number of abstinent participants with a history of de-
pendence on different substances. Although humans use
many different substances legally and illegally, heroin,
cocaine and alcohol are rated as the most harmful in the
UK (Nutt et al. 2010); these were the focus of the
present study. We hypothesised that AbDs would show
increased impulsivity across all modalities and that this
would be more marked in those with dependence on
multiple substances compared to those dependent on
alcohol alone. A secondary aim was to explore how impulsiv-
ity measures vary with length of abstinence, extending to
beyond 12 months.
Methods
This study was conducted as part of the ICCAM Platform
Study (www.iccam.org.uk), details of which are reported by
Paterson et al. (2015). The protocol was approved by theWest
London Research Ethics Committee (REC Ref: 11/H0707/9;
PI: Prof D.J. Nutt). Non-imaging testing sessions were con-
ducted at three sites: NIHR/Wellcome Trust Imperial Clinical
Research Facility, NIHR/Wellcome Trust Cambridge Clinical
Research Facility, and Clinical Trials Unit, Salford Royal
NHS Foundation Trust. Imaging sessions were conducted in
the adjoining centres at Imanova Limited (formerly the GSK
Clinical Imaging Centre), Wolfson Brain Imaging Centre,
Manchester Translational Imaging Unit (3T MRI Facility),
respectively.
Participants
Participants, including abstinent substance-dependent individ-
uals (AbDs) and controls, were recruited from local NHS ad-
diction services and via advertising on social media, in job
centres and libraries. Following written and informed consent,
all participants were assessed using the Structured Clinical
Interview for DSM-IV to assess for dependence history and
checked by a psychiatrist. Exclusion criteria for all partici-
pants included lifetime history of psychotic disorder, neuro-
logical illness, neurodevelopmental disorder or traumatic head
injury. Participants were between 20–65 years old and able to
read and write in English. To confirm abstinence on day of
testing, all participants completed an alcohol breath test
and urine drug screen. Participants were requested to
refrain from cannabis use for at least seven days prior
to each session but, given the long half-life of cannabi-
noid metabolites, positive results for cannabinoids were
permitted if the participant was not intoxicated or in
withdrawal (determined by the psychiatrist conducting
the interview). AbDs were abstinent for at least two
weeks prior to testing. Nicotine use was not an exclu-
sion criterion in any group as the majority of substance-
dependent individuals smoke tobacco.
Of the 179 participants who were consented to the study
across the three sites, 14 were excluded immediately at initial
screening by the researcher on the basis of obviously failing to
meet inclusion criteria (e.g. a history of psychosis). A further
22 participants were subsequently excluded by the clinical
committee at a second reviewing stage on the basis of more
subtle exclusions (e.g. controls with past cannabis use felt to
be approaching dependent levels). This left 143 who were
eligible for inclusion in analyses (21.7 % female, aged 25–
64, mean 41.66, SD 8.93) comprising 57 control participants
with no history of substance dependence (except nicotine),
and 86 abstinent substance-dependent participants (see Table 1).
The majority of substance-dependent participants had experience
with a large number of substances and many met criteria for
past dependence on multiple substances. For the purposes of
this study, we defined two substance-dependent groups:
Balcohol AbD^ participants who met DSM-IV criteria
for past dependence on alcohol (n = 27) and Bpolydrug
AbD^ participants who met DSM-IV criteria for past depen-
dence on two or more substances, one of which was alcohol,
cocaine or heroin (n=59; see Table 2).
Three control participants did not complete the behavioural
tasks, leaving 54 control participants in the behavioural anal-
ysis. Fourteen participants were removed from the GNG
imaging analysis due to excessive movement (defined as
>20 % volumes with >1 mm movement) or low baseline
performance on the GNG imaging task (<85 % Go accuracy),
leaving 52 control, 26 alcohol and 51 polydrug participants in
the imaging analysis.
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Assessment procedure
Clinical variables
Participants were interviewed to ascertain eligibility and
group allocation. We also obtained data on their substances
of dependence (excluding nicotine) and length of abstinence
(see Table 2). For alcohol AbD participants, length of
abstinence was calculated from their last use of alcohol
to dependent levels. For polydrug AbD participants the
multiple substances meant that length of abstinence
could only be calculated from the most recent use of
any substance of dependence.
Self-report questionnaires
Participants completed a battery of impulsivity questionnaires
presented in computer format. These included the Barratt
Impulsiveness Scale (BIS-11; Patton et al. 1995), Behaviour
Inhibition/Activation System (BIS/BAS; Carver and White
1994), the UPPS Impulsive Behaviour Scale (UPPS-P;
Whiteside and Lynam 2003) and the Obsessive-Compulsive
Inventory Revised (OCI-R; Foa et al. 2002).
Behavioural tasks
The Kirby test of delay discounting (Kirby and Maraković
1996) measures the discounting rate; the extent to which the
present value of a future reward decreases as the delay to its
receipt increases. Hypothetical immediate rewards of £11–80
and delayed rewards of £25–85, with delays of 7–186 days
were used. A hyperbolic discount parameter (k) score for each
participant was generated from the proportion of immediate
choices that were made over delayed choices using the meth-
od reported by Kirby et al. (1999); and Kirby (2000). Greater
discounting, indexed by increasing k values, indicates higher
levels of impulsivity.
Participants also completed the Stop Signal Task (SST) and
the Intra-Extra Dimensional Set Shift (IED) task from the
well-validated CANTAB neuropsychological test battery
(www.cambridgecognition.com/academic/cantabsuite/
executive-function-tests). The SST is a test of motor
inhibition, specifically action cancellation (Dalley et al.
2011), at the presentation of an auditory stimulus. A full de-
scription is presented by Ersche and Sahakian (2007). The
primary outcome is the Bstop-signal reaction time^ (SSRT),
which is the time an individual requires to withhold a
response.
The IED is derived from the Wisconsin Card Sorting Task
and assesses rule acquisition and reversal, visual discrimina-
tion, attentional set formation, maintenance, shifting and flex-
ibility of attention. Primary outcome measures are Btotal
errors^ (adjusted for any early terminations), Bnumber of
stages completed^ and Bnumber of errors at each stage^. A
full description is presented in Downes et al. (1989).
Functional MR imaging tasks
To investigate neural substrates of inhibitory control, partici-
pants performed a Go/NoGo (GNG) task whilst being scanned
using fMRI (Fig. 1). Participants were presented with a series
of individual BX’s^ and BY’s^ and asked to respond as quickly
Table 1 Demographic data for
control, alcohol dependent and
polydrug dependent participants
Control Alcohol Polydrug F or χ2 df p
Age (mean, SD) 42.39 (8.74) 45.81 (8.49) 39.05 (8.57) 6.034 2, 140 0.003
IQ (mean, SD) 107.88 (8.83) 104.85 (7.59) 99.32 (10.86) 11.904 2, 140 <0.001
% Female 26.3 22.2 16.9 1.504 2 0.471
% Smokers 56.1 74.1 76.3 5.979 2 0.050
Table 2 Substance dependence
data for control, alcohol
dependent and polydrug
dependent participant groups.
Data exclude nicotine
dependence
Control Alcohol Polydrug Total
Alcohol dependence No 57 0 23 80
Yes 0 27 36 63
Cocaine dependence No 57 27 14 98
Yes 0 0 45 45
Opioid dependence No 57 27 20 104
Yes 0 0 39 39
Length of abstinence (months) Alcohol Polydrug Polydrug (outlier removed)
Mean (SD) 15.46 (17.76) 20.86 (43.98) 15.63 (18.10)
Median 8.0 9.0 8.5
Range 1.0–79.0 0.5–324.0 0.5–102.0
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as possible to each letter by pressing a button (Go), except
when it immediately repeated itself (NoGo). This was an
event-related task carried out in two runs of 250 trials, each
containing 220 Go trials and 30 NoGo trials. This ratio of
frequent Go to rare NoGo trials was used as it is considered
a stronger test of pure inhibition than other Go:NoGo ratios
(Smith et al. 2014). Each letter was presented for 900 ms and
followed by 100 ms inter-stimulus interval of a blank screen.
Each run began with a 12-s fixation and lasted for 262 s.
Immediately before scanning, participants completed 60
practice trials.
MR image acquisition
Imaging was carried out at the three sites using a Siemens
(Imperial and Cambridge) or a Philips (Manchester) 3T MR
scanner. One hundred and thirty one volumes were acquired,
comprising 33–36 axial slices of 3 mm thickness, with a
TR of 2000 ms, TE of 32 ms and a voxel size of
3 × 3 × 3 mm. In order to maximise cerebral coverage
whilst minimising slice thickness and susceptibility arte-
fact, fMRI/EPI acquisition was at +30 degrees to the
ACPC line. A T1-weighted structural image was also
acquired for use in spatial pre-processing and for examination
of any structural abnormalities.
Data analysis
Self-report and behavioural data analysis
Data were analysed using Statistical Package for Social
Sciences (SPSS, version 22, www.spss.com) firstly using
multivariate analysis of variance (MANOVA) to asses overall
group differences. Where significant main effects were found,
these were explored with individual univariate analyses of
variance, and finally Tukey’s LSD post hoc test when
main effects from the univariate analyses were found.
Pearson’s Chi-square tests or independent t tests were
used to assess group differences in demographic vari-
ables. In order to explore important relationships be-
tween impulsivity measures and length of abstinence,
Pearson’s correlations were used within the AbD
groups. We also used Pearson’s correlation to explore
whether any of the measures where there were signifi-
cant group differences were related to age, IQ or smoking
status in the AbD groups.
Image analysis
Imaging data were analysed using statistical parametric map-
ping (SPM12; Wellcome Trust Centre for Neuroimaging,
London, England, http://www.fil.ion.ucl.ac.uk/spm/),
implemented in MATLAB (Mathworks 2012, www.
mathworks.com). Images were realigned to correct for
motion, using the first image as a reference. The structural
(T1-weighted) and functional images were then coregistered,
followed by spatial normalisation, and were smoothed using a
Gaussian kernel filter of 8×8×8 mm. First level analysis was
performed on the contrasts of BStops^ (successful inhibitions)
compared to a background of Go responding. Errors of com-
mission were modelled as a contrast of no interest as there
were too few for sufficient power. Also modelled as contrasts
of no interest were BSleep^, where there were more than 10
consecutive errors of omission on Go trials, and BFalse
Inhibitions^ where successful inhibitions on NoGo trials were
immediately preceded by an omitted Go trial.
The second level analysis used a region of interest (ROI)
approach based on areas previously identified in the inhibitory
control literature as being altered in substance dependence.
The areas identified were the right and left inferior frontal gyri
(IFG) and the anterior cingulate cortex (ACC), defined by
Neuromorphometrics, Inc. (www.neuromorphometrics.com),
under academic subscription (Supplementary Figure 1). We
extracted the average value of the Stops contrast per person
within each ROI and performed group comparisons using
independent-samples t tests in SPSS. Correlation analy-
ses were conducted by performing one-way ANOVAs
with the variables of BNoGo accuracy^ and Blength of
abstinence^ entered as separate covariates (p < 0.05,
Bonferroni corrected for three comparisons). To investi-
gate the relationship with length of abstinence, one
polydrug participant was removed due to an outlying
length of abstinence score (Table 2) and correlations
between BOLD signal in ROIs and length of abstinence
were then examined in the alcohol and polydrug AbD
groups.
Fig. 1 An instruction screen from the Go/NoGo task. Participants are
asked to respond as quickly as possible to each letter BX^ and BY^ that
appears on the screen, except when the letter is the same as the one shown
previously
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Results
Demographics and clinical variables
Participant group demographics can be seen in Table 1, whilst
additional dependencies and length of abstinence can be seen
in Table 2. One polydrug AbD participant was removed from
the length of abstinence analysis due to an outlying length of
abstinence of more than two standard deviations from the
mean. There were no differences in length of abstinence be-
tween alcohol and polydrug AbD participants (t(83)=−0.040,
p=0.968).
Normalisation of data
Initial data screening using Q-Q plots highlighted non-
normally distributed scores for IED total errors, Kirby and
OCI-R. Therefore, these data were transformed using a log
transformation, with the resulting Q-Q regressor plots show-
ing normal distribution.
Self-report measures
Multivariate analysis: group differences on total scores
The effect of group (control, alcohol AbD, polydrug
AbD) was analysed using a multivariate analysis of var-
iance (MANOVA) conducted on total scores for each of
the self-report measures of BIS-11, UPPS-P, BIS/BAS
and OCI-R. Using Pillai’s trace, a significant main ef-
fect of group was found (V= 0.395, F(10,274) = 6.741,
p< 0.001).
This significant main effect allowed separate univariate
analyses of variance (ANOVA) to be performed post
hoc on each of the outcome variables. These revealed
significant group differences on the total scores of BIS-11
(F(2,140) = 22.676, p<0.001), UPPS-P (F(2,140) = 39.284,
p < 0.001), BAS (F(2,140) = 6.319, p < 0.01) and OCI-R
(F(2,140) = 6.123, p< 0.01). There was no main effect of
group on BIS total (F(2,140) =1.414, p=0.247). Further post
hoc analysis using Tukey’s LSD revealed that both alcohol
and polydrug AbD groups scored significantly higher on the
BIS-11 (alcohol p < 0.01; polydrug p < 0.001), UPPS-P
(alcohol p< 0.001; polydrug p<0.001) and OCI-R (alcohol
p<0.05; polydrug p < 0.01) total scores than controls,
whilst only the polydrug AbD group scored significantly
higher than controls on BAS (p < 0.01) total scores
(Fig. 2 and Table 3).
Group differences on sub-scores
A second MANOVA was conducted to assess for group dif-
ferences on each of the questionnaire sub-scores. These
included the BIS-11 (Attentional Impulsivity, Motor
Impulsivity, Non-Planning Impulsivity), UPPS-P (Negative
Urgency, Premeditation, Perseverance, Sensation Seeking,
Positive Urgency), and BIS/BAS (Drive, Fun, Reward).
Using Pillai’s trace, a significant main effect of group was
found (V=0.567, F(22,262)=4.712, p<0.001), allowing for
separate univariate ANOVAs to be performed.
These post hoc ANOVAs revealed a significant group dif-
ference on BIS-11 Attentional Impulsivity (F(2,140) =19.128,
p<0.001), Motor Impulsivity (F(2,140) =8.751, p<0.001),
and Non-Planning Impulsivity (F(2,140) = 22.801,
p< 0.001); UPPS-P Negative Urgency (F(2,140) = 35.125,
p < 0.001), Premeditation (F(2,140) = 7.521, p < 0.01),
Perseverance (F(2,140) = 16.818, p < 0.001), Sensation
Seeking (F(2,140) = 6.882, p<0.01), and Positive Urgency
(F(2,140) = 26.695, p < 0.001); BIS/BAS Drive (F(2,
140)=5.249, p<0.01) and BIS/BAS Fun (F(2,140) =6.071,
p<0.01). There was no main effect of group on BIS/BAS
Reward (F(2,140)=1.766, p=0.175).
Further post hoc analysis using Tukey’s LSD revealed that
both alcohol and polydrug AbD groups scored significantly
higher than controls on BIS-11 Attentional Impulsivity (alco-
hol p<0.001; polydrug p<0.001), Motor Impulsivity (alcohol
p<0.05; polydrug p<0.001), and Non-Planning Impulsivity
(alcohol p<0.05; polydrug p<0.001), whilst polydrug partic-
ipants also scored significantly higher than alcohol partici-
pants on Non-Planning Impulsivity (alcohol p<0.05). Both
alcohol and polydrug AbD groups scored significantly higher
than controls on UPPS-P Negative Urgency (alcohol
p < 0.001; polydrug p < 0.001), Perseverance (alcohol
p<0.01; polydrug p<0.001), and Positive Urgency (alcohol
p<0.001; polydrug p<0.001). Polydrug AbD participants
scored significantly higher than controls on UPPS-P
Premeditation (p< 0.001), BIS/BAS Drive (p< 0.01) and
BIS/BAS Fun (p<0.01), as well as higher than both controls
and alcohol AbD participants on UPPS-P Sensation Seeking
(control p<0.01; alcohol p<0.05).
Behavioural tasks
The effect of group (control, alcohol AbD, polydrug AbD)
was analysed using a MANOVA on the score outcome mea-
sures for each of the behavioural tasks; SSRT, IED total errors
and Kirby k (Table 4). Using Pillai’s trace, a significant main
effect of group was found (V = 0.123, F(3,272) = 2.978,
p<0.01), allowing for separate univariate ANOVAs to be per-
formed. These post hoc ANOVAs revealed a significant group
difference on Kirby k (F(2,137) =6.244, p<0.01), but no sig-
nificant group differences on SSRT (F(2,137) = 0.822,
p=0.442) or IED total errors (F(2,137)= 2.402, p=0.094).
Further post hoc analysis using Tukey’s LSD revealed that
polydrug participants had significantly higher discounting
scores than controls (p< 0.01), whilst those of alcohol
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participants were only marginally higher than controls
(p= 0.054).
Additional exploratory analysis was performed on further
outcomemeasures of the SSTand IED in order to ensure these
were not confounding the results. All participants did not dif-
fer on Stop Signal Delay (F(2,137) = 0.369, p = 0.692),
Successful Stops (F(2,137) =1.292, p=0.278), or mean Go
Reaction Times (F(2,137) =0.203, p=0.816). There were no
significant group differences in the number of IED stages
completed (χ2 =10.321, p=0.413) nor number of errors at
each stage.
Length of abstinence
In each of the AbD groups, we conducted correlation
analyses on the measures where significant differences
from controls were observed to explore how these mea-
sures related to length of abstinence (Table 5). Shorter
length of abstinence was associated with higher scores
on BIS-11 Non-Planning Impulsivity (r=−0.44, p<0.05),
UPPS Negative Urgency (r = −0.41, p < 0.05) and
Premeditation (r=−0.38, p<0.05), as well as on BIS/BAS
Fun (r= −0.38, p < 0.05) within the alcohol AbD group.
Higher Kirby scores only were found to be associated with
shorter length of abstinence in the polydrug AbD group
(r=−0.40, p<0.01).
Correlation analyses associations with age, IQ
and smoking status
Correlation analyses were also conducted to assess whether
the variables of age, IQ and smoking status might explain the
variance in impulsivity measures across groups. We conduct-
ed analyses separately within the alcohol and polydrug AbD
groups on impulsivity measures where the groups differed
significantly from controls. There were no significant correla-
tions (see Supplementary Table 1).
FMRI analysis
AnANOVA showed no significant group difference in Go RT
(F(2,126) = 1.045, p = 0.355) or NoGo accuracy (F(2,
126) = 0.985, p=0.376). There was, however, a significant
difference in Go accuracy (F(2,126) = 4.402, p<0.05). Key
values are summarised in Table 6.
Independent t tests between alcohol dependent vs control,
polydrug dependent vs control, and alcohol dependent vs
polydrug dependent, did not identify any significant BOLD
signal changes at the voxel-level Family Wise Error (FWE)
corrected threshold of p<0.05. We also used the predefined
ROIs of right IFG, left IFG and ACC, none of which identified
any significant group differences. Correlation analyses found
no significant associations between activation and either
NoGo performance or length of abstinence.
Fig. 2 Total scores on self-report
measures for alcohol and
polydrug AbD groups plotted as
their difference from control
scores. *p< 0.05, **p < 0.01,
***p< 0.001
Table 3 Mean total scores (and
SD) for control, alcohol AbD and
polydrug AbD participants on
each of the self-report measures
Control Alcohol Polydrug
BIS-11 total 56.88 (9.45) 66.59 (12.63) 70.41 (11.58)
UPPS_P total 112.70 (19.27) 138.15 (24.72) 147.32 (21.83)
BIS/BAS BAS total 37.35 (5.68) 38.78 (6.01) 40.88 (4.71)
BIS/BAS BIS total 19.09 (4.28) 20.67 (3.96) 19.93 (4.20)
OCI total 7.40 (7.93) 13.59 (13.43) 13.02 (10.05)
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Effects of different dependency histories
Whilst numbers were too small for definitive analysis,
we performed an exploratory MANOVA of the 59
polydrug AbD participants to determine whether differ-
ences could be attributed to a specific history of depen-
dence on the most commonly used substances in our
sample (alcohol, opioids or stimulants). Using Pillai’s
trace, a significant main effect of past stimulant depen-
dence was found on total self-report scores (V= 0.189,
F(5,53) = 2.463, p< 0.05), which was found to be due to
those with a history of stimulant dependence scoring
significantly higher than those with no history of stim-
ulant dependence on the total scores of BIS-11 (F(1,
57) = 6.171, p < 0.05) , UPPS-P (F(1,57) = 7.596,
p < 0.01), BIS (F(1,57) = 5.886, p < 0.05) and OCI-R
(F(1,57) = 8.162, p<0.01), but not on BAS (F(1,57)=0.109,
p=0.742). There were no differential effects in those
with and without opioid use or alcohol use, and no
effects of any of the substances on behavioural or imaging
measures.
Discussion
This investigation compared self-report, behavioural and neu-
ral measures of impulsivity in a large abstinent substance-
dependent (AbD) population. We found that AbD participants
scored higher than controls on most self-report measures, but
that alcohol and polydrug dependent groups did not differ
from each other. In contrast, there were no group differences
on the fMRI GNG task or any of the behavioural measures of
impulsivity, except for the Kirby task. These findings add to
the growing literature on impulsivity in substance dependence
and point to the need for more appropriate and relevant
behavioural and neural impulsivity measures for AbD
individuals.
Self-report impulsivity
Both alcohol and polydrug AbD groups were found to be more
impulsive than controls across all self-report measures, except
the Behaviour Inhibition Scale, in line with previous literature
(Ersche et al. 2010, 2011; von Diemen et al. 2008). Although
the alcohol and polydrug AbD group scores were not signifi-
cantly different, there was a trend for the polydrug group to
score higher than the alcohol group, perhaps reflecting multiple
dependencies (McCown 1988; Semple et al. 2005).
The same pattern was also observed in the subscales of the
self-report measures, with both AbD groups scoring signifi-
cantly higher than control participants whilst not differing
from each other. There was one notable exception, with
polydrug AbD participants reporting more sensation seeking
than both controls and alcohol participants (who did not differ
from each other). This may be a result of prevalent stimulant
dependence history in the polydrug compared to the alcohol
AbD group. Stimulants such as cocaine and amphetamines
produce alterations in the mesolimbic dopaminergic system
(Volkow et al. 2011), which are associated with trait impulsiv-
ity (Dalley et al. 2011). Sensation seeking is particularly asso-
ciated with stimulant use (Ersche et al. 2010; Mahoney et al.
2015), and the higher scores in polydrug AbD participants in
our study could be consistent with their higher levels of stim-
ulant use. This is supported by our exploratory post hoc anal-
ysis that divided polydrug AbD participants by their specific
past dependencies, in which we found that only when stimu-
lant dependence history, and not opioid or alcohol dependence
Table 4 Mean (SD) scores for
each of control, alcohol and
polydrug groups on the three
behavioural measures of
impulsivity
Control Alcohol dependent Polydrug dependent
SSRT 183.61 (46.73) 190.98 (48.51) 195.31 (50.47)
IED errors (adj.) 26.11 (28.56) 34.52 (36.93) 34.19 (29.77)
Kirby k 0.02 (0.02) 0.04 (0.05) 0.04 (0.06)
Table 5 Correlation matrix for length of abstinence with measures of
impulsivity
Alcohol dependent Polydrug dependent
BIS-11 Total −0.344 −0.066
Attention −0.232 −0.007
Motor −0.226 −0.09
Non-planning −0.436* 0.054
UPPS-P Total −0.455* −0.198
Negative urgency −0.413* −0.188
Premeditation −0.381* −0.161
Perseverance −0.349 −0.086
Sensation seeking −0.044 −0.124
Positive urgency −0.368 −0.123
BIS/BAS Drive −0.257 0.006
Fun −0.382* −0.137
BAS total −0.344 −0.078
OCI-R Total 0.285 −0.010
Kirby k −0.019 −0.398**
*p< 0.05, **p< 0.01 (2-tailed)
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history, was used as a grouping variable was there a significant
difference on self-reported impulsivity. Whilst this suggests
that stimulant dependence may be a major determinant of
the increased impulsivity in our polydrug AbD group, these
findings should be taken with extreme caution due to the un-
balanced groups and low power of this analysis.
Although sensation seeking has been highly related to sub-
stance dependence (Zuckerman 2007), there is relatively little
evidence linking it directly to alcohol dependence (Noël et al.
2011). This is particularly notable in comparison to the wealth
of evidence of elevated sensation seeking in stimulant depen-
dence (e.g. Marusich et al. 2011; Mahoney et al. 2015; Ersche
et al. 2010; Stoops et al. 2007; Kelly et al. 2006; Patkar et al.
2004). However, the literature seems to focus more on sensa-
tion seeking as a risk factor for heavy drinking in adolescence
(e.g. Comeau et al. 2001; Shin et al. 2012; Gillespie et al.
2012). Additionally, impulsivity (specifically sensation seek-
ing and lack of premeditation) were found to be more related
to illicit substance use in young adults than was hazardous
drinking (Shin et al. 2013). To the best of our knowledge there
has not been an investigation comparing sensation seeking in
stimulant and alcohol dependence (either current or past)
within one study.
Behavioural and neural measures of impulsivity
There were no group differences on neural measures of im-
pulsivity, nor any of the behavioural measures except for the
Kirby delay discounting task. One explanation would be that
most of our behavioural and neural measures assess state im-
pulsivity, which undergoes change during and immediately
after dependence, whilst self-report measures (together with
the Kirby task) assess trait impulsivity that is relatively imper-
vious to such changes. Whilst this conclusion is intuitively
appealing, it is at odds with evidence of increased SST impul-
sivity in siblings of stimulant dependent individuals (Ersche
et al. 2011) implicating behavioural impulsivity as an
endophenotypic trait. It is also important to note that in the
present study, length of abstinence was related to BIS-11 Non-
Planning Impulsivity, UPPS-P Negative Urgency and
Premeditation, as well as BIS/BAS Fun within the alcohol
AbD group. Kirby discounting scores were also seen to de-
crease with length of abstinence within the polydrug AbD
group. Thus self-reported (and Kirby discounting) impulsivity
appear to decrease with extended abstinence, a pattern not
entirely consistent with the hypothesis that self-reported im-
pulsivity is a stable trait. However, the pattern we observed
could also be explained by lower levels of trait impulsivity in
those able to maintain longer term abstinence. A longitudinal
approach would be required to distinguish these possibilities.
Another consideration is that self-report measures of impul-
sivity are more susceptible to bias (Verdejo-García et al.
2008), intentional or otherwise, whilst behavioural tasks are
much less prone to this bias. Therefore, this begs the question
of whether this bias is driving the self-report impulsivity dif-
ferences rather than Btrue impulsivity .^ This may be particu-
larly pertinent for abstinent individuals who have learned to
inhibit potentially instinctive impulsive behaviours to main-
tain abstinence.
Of the explicit behavioural measures used here, only the
Kirby discounting scores were seen to decrease with extended
abstinence within the polydrug dependent group. Another in-
terpretation is that the SST, IED and GNG simply do not
capture the most relevant aspects of impulsivity in AbDs,
whilst the self-report measures used in this study (as well as
the Kirby) are more sensitive to detecting differences. SST,
GNG and, to a lesser extent, IED measure inhibition of motor
responses and none of these tasks include emotional or moti-
vational components. By contrast, many of the self-report
scales for which we found significant group differences mea-
sure how an individual reacts to emotional states, such as the
UPPS-P Negative Urgency subscale, which is sensitive to
differences between dependent individuals (Torres et al.
2013) as well as pathological gamblers (Clark et al. 2012).
Similarly, the Kirby behavioural task involves the motivation-
ally salient/ emotionally relevant cue of money. Although
Bcold cognitive^ tests such as the GNG, SST and IED used
here are used widely in the addiction literature, and have been
found to be sensitive to current and very recent dependence, it
may be that more Bhot cognitive^ tests, that include emotional
and motivational dimensions, are required to detect differ-
ences in groups able to maintain abstinence.
Therefore, there is a need for validated behavioural mea-
sures that assess Baffective impulsivity ,^ in a way that incor-
porates motivational and emotional components known to be
important in both developing substance dependence
(Andersen and Teicher 2009; Woicik et al. 2009), and later
relapse (Koob and Le Moal 2001). Thus impulsivity tests like
the Kirby that involve decision-making about motivationally
salient cues may also prove more sensitive than simple motor
Table 6 Mean (SD) performance
scores for each group on GNG
fMRI task
Control Alcohol dependent Polydrug dependent
Go accuracy (%) 98.58 (2.15) 97.68 (2.71) 96.79 (3.91)
NoGo accuracy (%) 69.49 (15.58) 65.24 (17.65) 65.05 (18.92)
Go RT (ms) 340.18 (72.10) 318.16 (64.75) 341.64 (74.89)
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impulsivity tasks. The multidimensional nature of impulsivity
(Evenden 1999; Bari and Robbins 2013) suggests that multi-
ple tasks are required to assess the construct comprehensively
and our findings highlight the need for more extensive cogni-
tive and behavioural impulsivity assessment in AbDs.
Length of abstinence
It is also important to note that in the present study, length of
abstinence was related to BIS-11 Non-Planning Impulsivity,
UPPS-P Negative Urgency and Premeditation, as well as BIS/
BAS Fun within the alcohol AbD group. Kirby discounting
scores were also negatively correlated with length of absti-
nence within the polydrug AbD group. Thus self-reported
(and Kirby discounting) impulsivity appears to decrease with
extended abstinence, a pattern not entirely consistent with the
hypothesis that self-reported impulsivity is a stable trait.
However, the pattern we observed could also be explained
by lower levels of trait impulsivity in those able to maintain
longer term abstinence. Unfortunately, the nature of the design
of this study is such that we cannot determine whether impul-
sivity predated or is a consequence the individuals’ drug use.
A longitudinal approach would be required to distinguish
these possibilities.
Nevertheless, length of abstinence is an important point of
variation between previous studies in this area. Ersche et al.’s
(2011) stimulant dependent individuals who showed in-
creased impulsivity were not abstinent. Recently Naim-Feil
et al. (2014) reported persisting impulsivity in abstinent alco-
hol dependent participants with a mean duration of abstinence
of approximately 6 months. In our sample, mean length of
abstinence was over 12 months and may have allowed indi-
viduals time for significant cognitive improvement. Although
there is some evidence of improvement of inhibitory control
with abstinence (Hopwood et al. 2011; Morie et al. 2014),
including functioning of relevant neural circuits (Bell et al.
2014), there is also evidence of an improvement in executive
functioning (Schulte et al. 2014; Stavro et al. 2013; Sullivan
et al. 2000), into which inhibitory control can be included as a
wider construct (see also a review by Fernández-Serrano et al.
2011). Consistent with the idea of recovery of executive func-
tions, including inhibitory control, we found less impulsive
performance on the Kirby task to be associated with longer
abstinence in the polydrug AbD group.
Alternatively, including only stably abstinent participants
may have biased our sample towards individuals with lower
cognitive impulsivity, since the most impulsive individuals
prone to early relapse will have been excluded. Early relapse
and poor treatment retention are associated with higher impul-
sivity in stimulant dependence, (Moeller et al. 2001; Patkar
et al. 2004) and alcohol dependence (Evren et al. 2012), al-
though not in opioid dependence (Passetti et al. 2008).
Nevertheless, the correlations between self-report measures
and length of abstinence were relatively weak and do not
explain all of the variance. Self-reported impulsivity is thus
elevated even in those with long-term abstinence.
Limitations
A limitation of this study is that the polydrugAbD participants
had past dependence on a wide range of substances with sub-
stantially different individual profiles of dependent and non-
dependent use. Whilst the cohort was representative of the
substance-dependent population in the UK, this heterogeneity
precluded systematic analysis of the contribution of different
substances to the effects observed. For example, the specific
contribution of a history of stimulant dependence to impulsiv-
ity was impossible to isolate. Poly-substance use is an impor-
tant issue in addiction research, particularly the potential dis-
tinction of dependence on stimulants from other substances,
with some studies suggesting that opioid dependence is
behaviourally distinct from stimulant dependence (Badiani
et al. 2011; Vassileva et al. 2014). Thus, for example, high
impulsivity in opioid use has been suggested to be a result
of drug use rather than a risk factor in the development of
dependence (Harty et al. 2011; Schippers et al. 2012), by
contrast to stimulant dependence where high impulsivity is a
well-established risk factor (Dalley et al. 2011; Ersche et al.
2010). In addition, a recent paper by Whelan et al. (2014)
showed that impulsivity played a relatively minor role in the
development of alcohol dependence. However, the clinical
reality of drug addiction in the UK is a very high prevalence
of poly-substance use and dependence; a meta-analysis by
Smith et al. (2014) noted that there was little consistency
across studies in the recording of the amount or length of drug
use, pointing out that many findings need to be considered
with caution. Thus, it is difficult to study single dependencies
empirically and the practical clinical relevance of doing so is
questionable, as polydrug dependency is the more common
clinical challenge.
As a result of these difficulties in recruiting individuals
with single dependencies (excluding nicotine), our alcohol
group was relatively small (n=26), only providing sufficient
power to detect moderate effect sizes (Smith et al. 2014). It
may be more valuable for future investigations to consider all
AbD participants as one group and investigate their different
profiles that are not based on the substances used.
Another limitation of this study is that the groups differed
on the measures of age, IQ and smoking status. Nevertheless,
these variables were not found to correlate with any of the
group differences identified in the present results, implying
that they were not responsible for the differences found. It is
perhaps surprising that there were such weak correlations be-
tween performance on the cognitive tasks and IQ. This is in
line with some previous studies, but not all; for example a
large recent study reported a significant correlation between
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IQ and delay discounting (de Wit et al. 2007). However it
should be noted that other aspects of impulsivity were not
related to IQ in that study, and furthermore the effect was
observed in a much larger sample than that studied here and
with a mean IQ markedly higher.
In addition, the high upper age range of participants within
this study (65 years) may have introduced an age-related bias
in impulsivity. There is substantial evidence of brain atrophy
with older age, for example the rate of cortical atrophy in-
creases to 0.35 % a year after the age of 52, compared to
0.12 % in young adulthood, ventricle size expands at rate of
4.25% after 70 years compared to 0.43% in young adulthood,
whilst the frontal lobes, which are involved in inhibitory con-
trol, show the steepest decline (for a review, see Dennis and
Cabeza 2011). In addition, older adults show more compen-
sation for poorer inhibitory control that declines with increas-
ing age (Nielson et al. 2002), as well as poorer motor control
(Levin et al. 2014). However, neither AbD group in the pres-
ent study differed significantly in age from the control group
(although the alcohol and polydrug groups differed) nor none
of the variables showing group differences were correlated
with age.
Conclusion
The present study suggests that the self-report measures used
are more sensitive to detecting impulsivity in long-term absti-
nent individuals than the behavioural or neuronal measures.
Our findings suggest the importance of developing behaviour-
al measures that assess different aspects of impulsivity rather
than simple motor response inhibition, alongside correspond-
ing behavioural challenges to use in conjunction with fMRI. A
complementary approach may be to reconsider the grouping
of individuals in studies of dependence, with a shift of empha-
sis to cognitive endophenotypes rather than specific sub-
stances used. Such an approach would obviate the problem
of categorising individuals with complicated drug use and
dependence histories, and would have implications for
optimising approaches to treatment and prevention based on
cognitive profiles.
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